GOLGA6A

Across TCGA pan-cancer cohorts, GOLGA6A RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated GOLGA6A data layer compared with 1 for mutation status.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher GOLGA6A RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated GOLGA6A expression acts as an unfavorable survival marker, although some lineages such as OV and ESCA show a favorable association.

OV, THCA, and LUAD are the cancer types where GOLGA6A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.236	0.151	.003	54	view →
THCA	DFS	Tertile	III,IV	0.685	0.870	.001	54	view →
LUAD	OS	Tertile	II,III,IV	0.103	0.334	.002	40	view →
KIRC	DFS	Tertile	II,III,IV	0.421	0.596	.009	24	view →
PCPG	DFS	Quartile	All	0.463	0.903	.005	24	view →
ESCA	OS	Median	IV	0.743	0.290	.013	23	view →
COAD	OS	Tertile	All	0.629	0.828	.006	18	view →
READ	DFS	Tertile	II,III,IV	0.642	0.835	.036	12	view →
UVM	DFS	Tertile	III,IV	0.215	0.618	.016	10	view →
MESO	DFS	Median	II,III,IV	0.352	0.201	.012	10	view →
LIHC	OS	Quartile	All	0.754	0.489	.017	8	view →
SKCM	DFS	Tertile	All	0.684	0.591	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

GOLGA6A–OV (DFS)

Open the OV breakdown →